Neustein Rebecca F, Bruce Beau B, Beck Allen D
Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.
Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.
Am J Ophthalmol. 2016 Oct;170:214-222. doi: 10.1016/j.ajo.2016.08.012. Epub 2016 Aug 18.
To report and compare visual and glaucoma outcomes in primary congenital glaucoma (PCG) vs glaucoma following congenital cataract surgery (GFCS).
Retrospective, observational, comparative case series.
Setting: Emory Eye Center, Atlanta, Georgia.
Pediatric glaucoma patients (age 0-18 years) treated at Emory by 1 clinician with ≥2-year follow-up. Glaucoma was defined according to the 9th Consensus Report of the World Glaucoma Association.
Snellen-equivalent logMAR visual acuity (VA) and glaucoma control (IOP ≤21, no devastating complications, no recommendation for further glaucoma surgery). Asymptotic Wilcoxon-Mann-Whitney rank sum tests were employed to compare glaucoma subgroups.
Included were 72 PCG and 56 GFCS cases, with mean follow-up time of 7.4 ± 4.1 and 8.0 ± 3.8 years, respectively. At last follow-up, PCG showed better median VA than GFCS in worse-seeing eyes (20/60 [interquartile range (IQR) 20/30-20/200] vs 20/400 [IQR 20/70-hand motion], respectively, P < .0001) and in better-seeing eyes of bilaterally-affected children (20/30 [IQR 20/20-20/60] vs 20/70 [IQR 20/35-20/100], respectively, P = .024).The following variables characterized the PCG and GFCS groups' glaucoma status, respectively: mean age at diagnosis (years), 0.70 ± 1.3 vs 3.3 ± 3.5 (P < .0001); median IOP (mm Hg), 15.50 [IQR 12.1-19.4] vs 17.50 [IQR 14.9-22], P = .037; median number of glaucoma medications at last follow-up, 1.49 [IQR 0-2] vs 2.54 [IQR 1-4], P < .0001; median number of glaucoma surgeries, 1.0 [IQR 1-2] vs 1.25 [IQR 0.5-2.0], P = .09.
Children with PCG (vs those with GFCS) presented earlier, had better vision, required fewer medications to control disease, and had lower IOP at last follow-up.
报告并比较原发性先天性青光眼(PCG)与先天性白内障手术后青光眼(GFCS)的视力和青光眼治疗效果。
回顾性、观察性、比较性病例系列研究。
研究地点为佐治亚州亚特兰大市的埃默里眼科中心。
在埃默里眼科中心由1名临床医生治疗且随访时间≥2年的小儿青光眼患者(年龄0 - 18岁)。青光眼的定义依据世界青光眼协会第9次共识报告。
Snellen等效对数最小分辨角视力(VA)和青光眼控制情况(眼压≤21,无严重并发症,无需进一步进行青光眼手术)。采用渐近性Wilcoxon - Mann - Whitney秩和检验比较青光眼亚组。
纳入72例PCG病例和56例GFCS病例,平均随访时间分别为7.4 ± 4.1年和8.0 ± 3.8年。在末次随访时,PCG组视力较差眼的中位视力优于GFCS组(分别为20/60[四分位间距(IQR)20/30 - 20/200]和20/400[IQR 20/70 - 手动视力],P <.0001),在双眼受累儿童视力较好眼方面也如此(分别为20/30[IQR 20/20 - 20/60]和20/70[IQR 20/35 - 20/100],P =.024)。以下变量分别表征了PCG组和GFCS组的青光眼状况:诊断时的平均年龄(岁),0.70 ± 1.3与3.3 ± 3.5(P <.0001);眼压中位数(mmHg),15.50[IQR 12.1 - 19.4]与17.50[IQR 14.9 - 22],P =.03